Syros Pharmaceuticals Inc... (SYRS)
NASDAQ: SYRS
· Real-Time Price · USD
0.03
0.00 (20.00%)
At close: Jun 06, 2025, 1:58 PM
0.03
0.00%
After-hours: Jun 06, 2025, 01:58 PM EDT
20.00% (1D)
| Bid | n/a |
| Market Cap | 673.5K |
| Revenue (ttm) | 386K |
| Net Income (ttm) | -97.81M |
| EPS (ttm) | -3.07 |
| PE Ratio (ttm) | -0.01 |
| Forward PE | -0.04 |
| Analyst | Hold |
| Ask | n/a |
| Volume | 13,961 |
| Avg. Volume (20D) | 20,465,601 |
| Open | 0.03 |
| Previous Close | 0.03 |
| Day's Range | 0.03 - 0.03 |
| 52-Week Range | 0.01 - 6.93 |
| Beta | 1.56 |
About SYRS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SYRS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SYRS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
-42.74%
Syros Pharmaceuticals shares are trading lower aft...
Unlock content with
Pro Subscription
6 months ago
+39.24%
Syros Pharmaceuticals shares are trading higher after falling on Monday after the company announced it gave notice to QIAGEN Manchester of its election to terminate the Master Collaboration Agreement.
3 months ago · businesswire.com
Syros Announces Voluntary Delisting from Nasdaq and SEC DeregistrationCAMBRIDGE, Mass.--(BUSINESS WIRE)--Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) (the “Company”) today announced that its Board of Directors (the “Board”) has approved and the Company intends to proceed w...